Just In
HCL FY26 Guidance: Revenue growth expected to be between 3.0%-5.0% YoY in CC
HCL reported revenue of $3,545 million in USD terms, marking a 1.3% increase QoQ and 5.4% growth YoY
HCL's revenue in constant currency declined 0.8% quarter-on-quarter but grew 3.7% year-on-year
HCL FY26 Guidance: Revenue growth expected to be between 3.0%-5.0% YoY in CC
HCL reported revenue of $3,545 million in USD terms, marking a 1.3% increase QoQ and 5.4% growth YoY
HCL's revenue in constant currency declined 0.8% quarter-on-quarter but grew 3.7% year-on-year

sun pharma concert

(1 search result)

Sun Pharma to buy U.S. drug firm Concert for $576 mn